No doubt its the same buyer that precipitated the drive through resistance yesterday.
And he's stepped right up to the plate.
The bigger players aren't taking any prisioners here but when you see where the targets are and the business plan it isn't hard to see why.
Trade wisely but the potential looks excellent.
The above is my opinion only of course, please do your own research.
Cheers,
- Forums
- ASX - By Stock
- CUS
- buyers back and he's serious
buyers back and he's serious
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUS (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
-0.001(1.64%) |
Mkt cap ! $6.737M |
Open | High | Low | Value | Volume |
6.2¢ | 6.2¢ | 6.0¢ | $4.51K | 74.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 399136 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 29860 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 399136 | 0.060 |
2 | 117543 | 0.057 |
1 | 75000 | 0.056 |
2 | 58310 | 0.052 |
2 | 22197 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.062 | 29860 | 1 |
0.065 | 30000 | 1 |
0.070 | 42241 | 2 |
0.074 | 50000 | 1 |
0.078 | 10000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
CUS (ASX) Chart |